Page 11 of 26, showing 50 records out of 1263 total, starting on record 501, ending on 550
| Publication |
Category |
Year |
|
3915. Labrie, F. (1993) Let me count the ways. Scientific evaluation. Measure for Measure in Science [Letter to the Editor re: Taubes 260: 884-6, 1993]. Science, 261: 145. |
All publications |
1993 |
|
136. Labrie, F. (1993) Mechanism of action and pure antiandrogenic properties of Flutamide. Cancer, 72: 3816-3827. |
All publications |
1993 |
|
137. Labrie, F. (1993) Non-steroidal antiandrogens, in: Droz, J.P., Cvitkovic, E., Armand, J.P. et Khoury, S., eds: Handook of Chemotherapy in Clinical Oncology, London, Scientific Communication International Ltd., pp 389-391. |
All publications |
1993 |
|
138. Labrie, F. (1993) Present status of endocrine therapy of prostate cancer. Eur. Urol. Today, 3: 10-11. |
All publications |
1993 |
|
139. Labrie, F., Bélanger, A., Dupont, A., Luu-The, V., Simard, J., Labrie, C. (1993) Science behind total androgen blockade: from gene to combination therapy. Clin. Invest. Med., 16: 475-492. |
All publications |
1993 |
|
140. Labrie, F., Bélanger, A., Simard, J., Labrie, C., Dupont, A. (1993) Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first line therapy. Cancer, 71: 1059-1067. |
All publications |
1993 |
|
3924. Labrie, F., Dupont, A., Cusan, L., Gomez, J.-L., Diamond, P. (1993) Major advantages of "early" administration of endocrine combination therapy in advanced prostate cancer. Clin. Invest. Med., 16: 493-498. |
All publications |
1993 |
|
142. Labrie, F., Dupont, A., Cusan, L., Gomez, J.L., Diamond, P., Koutsilieris, M., Suburu, R., Fradet, Y., Lemay, M., Tetu, B., Emond, J., Candas, B. (1993) Downstaging of localized prostate cancer by neoadjuvant therapy with Flutamide and Lupron. Clin. Invest. Med., 16: 499-509. |
All publications |
1993 |
|
143. Labrie, F., Dupont, A., Simard, J., Luu-The, V., Bélanger, A. (1993) Intracrinology: the basis for the rational design of endocrine therapy at all stages of prostate cancer. Eur. Urol., 24 Suppl. 2: 94-105. |
All publications |
1993 |
|
144. Labrie, F., Dupont, A., Suburu, R., Cusan, L., Gomez, J.L., Koutsilieris, M., Diamond, P., Emond, J., Lemay, M., Candas, B. (1993) Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen. Clin. Invest. Med., 16: 425-439. |
All publications |
1993 |
|
469. Labrie, F., Li, S., Bélanger, A., Côté, J., Mérand, Y., Lepage, M. (1993) Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethylbenz(a)anthracene in the rat. Breast Cancer Res. Treat., 26: 253-265. |
All publications |
1993 |
|
963. Labrie, F., Simard, J., Luu-The, V., Pelletier, G., Labrie, C., Dupont, E., Martel, C., Couet, J., Trudel, C., Rhéaume, E., Breton, N., de Launoit, Y., Dumont, M., Zhao, H.F., Lachance, Y. (1993) Structure and control of expression of the 3β-HSD and 17β-HSD genes in classical steroidogenic and peripheral intracrine tissues, in: Leung, P.C.K., Hsueh, A.J.W. et Friesen, H.G., eds: Molecular Basis of Reproductive Endocrinology, New York, Karger, pp 112-143. |
All publications |
1993 |
|
470. Li, S., Yan, X., Bélanger, A., Labrie, F. (1993) Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(?)anthracene (DMBA) in the rat. Breast Cancer Res. Treat., 29: 203-217. |
All publications |
1993 |
|
3886. Li, S., Yan, X., Bélanger, A., Labrie, F. (1993) Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)antrhracene (DMBA) in the rat. Breast Cancer Res Treat, 29: 203-217. |
All publications |
1993 |
|
145. Martel, C., Trudel, C., Couet, J., Labrie, C., Bélanger, A., Labrie, F. (1993) Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA. Mol. Cell. Endocrinol., 91: 43-49. |
All publications |
1993 |
|
146. Normand, T., Narod, S., Labrie, F., Simard, J. (1993) Detection of polymorphisms in the estradiol 17β-hydroxysteroid dehydrogenase II gene at the human EDH17B2 locus on 17q11-q21. Hum. Mol. Genet., 2: 479-483. |
All publications |
1993 |
|
967. Riley, S.C., Bassett, N.S., Berdusco, E.T., Yang, K., Leystra-Lantz, C., Luu-The, V., Labrie, F., Challis, J.R. (1993) Changes in the abundance of mRNA for type I 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in the human placenta and fetal membranes during pregnancy and labor. Gynecol. Obstet. Invest., 35: 199-203. |
All publications |
1993 |
|
3934. Schulman, C.C., Debruyne, F.M., Ekman, P., Labrie, F. (1993) Workshop summary: Hormonal suppression in the neoadjuvant setting and advanced disease. Eur. Urol., 24: 61-63. |
All publications |
1993 |
|
367. Simard, J., Couet, J., Durocher, F., Labrie, Y., Sanchez, R., Breton, N., Turgeon, C., Labrie, F. (1993) Structure and tissue-specific expression of a novel member of the rat 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) family: the exclusive 3β-HSD gene expressed in the skin. J. Biol. Chem., 268: 19659-19668. |
All publications |
1993 |
|
472. Simard, J., Feunteun, J., Lenoir, G., Tonin, P., Normand, T., Luu-The, V., Vivier, A., Lasko, D., Morgan, K., Rouleau, G.A., Lynch, H., Labrie, F., Narod, S.A. (1993) Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum. Mol. Genet., 2: 1193-1199. |
All publications |
1993 |
|
969. Simard, J., Rhéaume, E., Sanchez, R., de Launoit, Y., Laflamme, N., Luu-The, V., van Seters, A.P., Gordon, R.D., Heinrich, U., Moshang, T., New, M.I., Labrie, F. (1993) Molecular basis of congenital adrenal hyperplasia due to 3?-hydroxysteroid dehydrogenase deficiency. Mol. Endocrinol., 7: 716-728. |
All publications |
1993 |
|
970. Couët, J., Simard, J., Martel, C., Trudel, C., Labrie, Y., Labrie, F. (1992) Regulation of 3-ketosteroid reductase mRNA levels and 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase activity in rat liver by sex steroids and pituitary hormones. Endocrinology, 131: 3034-3044. |
All publications |
1992 |
|
971. de Launoit, Y., Simard, J., Durocher, F., Labrie, F. (1992) Androgenic 17β-hydroxysteroid dehydrogenase activity of expressed rat type I 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase. Endocrinology, 130: 553-555. |
All publications |
1992 |
|
972. de Launoit, Y., Zhao, H.F., Bélanger, A., Labrie, F., Simard, J. (1992) Expression of liver specific member of the 3β-hydroxysteroid dehydrogenase family, an isoform possessing an almost exclusive 3-keto steroid reductase activity. J. Biol. Chem., 267: 4513-4517. |
All publications |
1992 |
|
973. Dumont, M., Luu-The, V., de Launoit, Y., Labrie, F. (1992) Expression of human 17β-hydroxysteroid dehydrogenase in mammalian cells. J. Steroid Biochem. Mol. Biol., 41: 605-608. |
All publications |
1992 |
|
368. Dumont, M., Luu-The, V., Dupont, E., Pelletier, G., Labrie, F. (1992) Characterization, expression and immunohistochemical localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in human skin. J. Invest. Dermatol., 99: 415-421. |
All publications |
1992 |
|
3943. Dupont, A., Labrie, F., Cusan, L., Gomez, J.L., Tremblay, M., Lacourciere, Y., Emond, J., Monfette, G. (1992) Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer. Recent Results Cancer Res., 124: 43-54. |
All publications |
1992 |
|
3944. Dupont, A., Moorjani, S., Cusan, L., Dupont, P., De Lignières, B., Mailloux, J., Gomez, J.L., Labrie, F. (1992) Effect of progesterone on cholesterol and lipoproteins during hormonal replacement therapy, in: Lobo, R. et Naftolin, F., eds: Progesterone in Hormonal Replacement Therapy, New Jersey, USA, The Parthenon Publishing Group, pp 37-46. |
All publications |
1992 |
|
975. Dupont, E., Labrie, F., Luu-The, V., Pelletier, G. (1992) Immunocytochemical localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) in human ovary. J. Clin. Endocrinol. Metab., 74: 994-998. |
All publications |
1992 |
|
147. Gomez, J.L., Dupont, A., Cusan, L., Tremblay, M., Suburu, E.R., Lemay, M., Labrie, F. (1992) Incidence of liver toxicity associated with the use of Flutamide in prostate cancer patients. Am. J. Med., 92: 465-470. |
All publications |
1992 |
|
148. Gomez, J.L., Dupont, A., Cusan, L., Tremblay, M., Tremblay, M., Labrie, F. (1992) Simultaneous liver and lung toxicity related to the non-steroidal antiandrogen Nilutamide (Anandron): a case report. Am. J. Med., 92: 563-566. |
All publications |
1992 |
|
473. Labrie, C., Martel, C., Dufour, J.M., Lévesque, C., Mérand, Y., Labrie, F. (1992) Novel compounds inhibit estrogen formation and action. Cancer Res., 52: 610-615. |
All publications |
1992 |
|
3951. Labrie, F. (1992) Faits et logique. Médecine/Sciences, 8: 708-9. |
All publications |
1992 |
|
3950. Labrie, F. (1992) Projet de loi C-91. Chambre des Communes, Fascicule #7A: 305-333. |
All publications |
1992 |
|
149. Labrie, F. (1992) Stratégie efficace et peu coûteuse pour la détection du cancer de la prostate à un stade précoce alors que la guérison est possible. Médecine/Sciences, 8: 703-706. |
All publications |
1992 |
|
150. Labrie, F., Dupont, A., Cusan, L., Gomez, J., Emond, J., Monfette, G. (1992) Combination therapy with Flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer (8-year clinical experience) and extension to early stages of the diseases, in: Carpi, A., Sagripanti, A. et Mittermayer, eds: Progress in Clinical Oncology, Italy, Sympomed Verlag, pp 278-293. |
All publications |
1992 |
|
151. Labrie, F., Dupont, A., Cusan, L., Suburu, E.R., Gomez, J.L., Thibault, M.M., Tremblay, M. (1992) Perspectives dans le diagnostic et le traitement du cancer de la prostate au stade précoce, in: Bonjour, J.P., Gayraud, M.,Guillevin, L. et Rizzoli, R., eds: Nouvelles statégies thérapeutiques en cancérologie, rapports présentés au XLVIIIe Congrès Français de Médecine, Montréal 1991, Alertes carcinologiques, pp 25-44. |
All publications |
1992 |
|
152. Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Gomez, J.L., Emond, J. (1992) Serum prostate specific antigen (PSA) as prescreening test for prostate cancer. J. Urol., 147: 846-851. |
All publications |
1992 |
|
474. Labrie, F., Simard, J., de Launoit, Y., Poulin, R., Thériault, C., Dumont, M., Dauvois, S., Martel, C., Li, S.; (1992) Androgens and breast cancer. Cancer Detect. Prev., 16: 31-38. |
All publications |
1992 |
|
978. Labrie, F., Simard, J., Luu-The, V., Bélanger, A., Pelletier, G. (1992) Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J. Steroid Biochem. Mol. Biol., 43: 805-826. |
All publications |
1992 |
|
979. Labrie, F., Simard, J., Luu-The, V., Pelletier, G., Bélanger, A. (1992) Cloning, expression and regulation of tissue-specific expression of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in Cellular and Molecular Biology of the Adrenal Cortex, London, John Libbey Eurotext Ltd., pp 89-109. |
All publications |
1992 |
|
980. Labrie, F., Simard, J., Luu-The, V., Pelletier, G., Bélanger, A., Lachance, Y., Zhao, H.F., Labrie, C., Breton, N., de Launoit, Y., Dumont, M., Dupont, E., Rhéaume, E., Martel, C., Couët, J., Trudel, C. (1992) Structure and tissue-specific expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues. J. Steroid Biochem. Mol. Biol., 41: 421-435. |
All publications |
1992 |
|
981. Labrie, F., Sugimoto, Y., Luu-The, V., Simard, J., Lachance, Y., Bachvarov, D., Leblanc, G., Durocher, F., Paquet, N. (1992) Structure of human type II 5α-reductase gene. Endocrinology, 131: 1571-1573. |
All publications |
1992 |
|
475. Li, S., Lepage, M., Mérand, Y., Bélanger, A., Labrie, F. (1992) Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate. Breast Cancer Res. Treat., 24: 127-137. |
All publications |
1992 |
|
982. Lin, S.-X., Yang, F., Jin, J.-Z., Breton, R., Zhu, D.-W., Luu-The, V., Labrie, F. (1992) Subunit identity of the dimeric 17β-hydroxysteroid dehydrogenase from human placenta. J. Biol. Chem., 267: 16182-16187. |
All publications |
1992 |
|
983. Martel, C., Rhéaume, E., Takahashi, M., Trudel, C., Couët, J., Luu-The, V., Simard, J., Labrie, F. (1992) Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. Mol. Biol., 41: 597-603. |
All publications |
1992 |
|
153. Martel, C., Trudel, C., Couet, J., Labrie, C., Bélanger, A., Labrie, F. (1992) Blockade of androgen action by combined treatment with a pure antiandrogen (Flutamide) and a 5α-reductase inhibitor (4-MA), in: Giuliani, L. et Puppo, P., eds: Urology, Bologna, Monduzzi Editore, pp 605-610. |
All publications |
1992 |
|
985. Pelletier, G., Dupont, E., Simard, J., Luu-The, V., Bélanger, A., Labrie, F. (1992) Ontogeny and subcellular localization of 3β-hydroxysteroid dehydrogenase (3β-HSD) in the human and rat adrenal, ovary and testis. J. Steroid Biochem. Mol. Biol., 43: 451-467. |
All publications |
1992 |
|
154. Pinault, S., Têtu, B., Gagnon, J., Monfette, G., Dupont, A., Labrie, F. (1992) Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination therapy with flutamide. Urology, 39: 254-261. |
All publications |
1992 |
|
987. Rösler, A., Bélanger, A., Labrie, F. (1992) Mechanisms of androgen production in male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab., 75: 773-778. |
All publications |
1992 |